Renaissance Technologies - OCUPHIRE PHARMA INC ownership

OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 50 filers reported holding OCUPHIRE PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of OCUPHIRE PHARMA INC
ValueSharesWeighting
Q2 2023$432
-39.3%
99,600
-47.6%
0.00%0.0%
Q1 2023$712
+6.4%
189,969
+0.2%
0.00%0.0%
Q4 2022$669
-99.8%
189,500
-8.4%
0.00%0.0%
Q3 2022$416,000
+9.2%
206,901
+4.4%
0.00%
Q2 2022$381,000
+429.2%
198,190
+923.7%
0.00%
Q4 2021$72,000
-61.7%
19,361
-45.5%
0.00%
Q2 2021$188,000
-71.5%
35,529
-68.7%
0.00%
-100.0%
Q1 2021$660,000
+37.8%
113,620
+53.9%
0.00%0.0%
Q4 2020$479,00073,8200.00%
Other shareholders
OCUPHIRE PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Richmond Brothers, Inc. 340,526$1,276,9762.16%
Knoll Capital Management, LLC 100,000$375,0000.58%
RICE HALL JAMES & ASSOCIATES, LLC 809,117$3,034,1890.17%
Diametric Capital, LP 55,648$208,6800.10%
MAI Capital Management 494,690$1,855,0880.03%
TRUST CO OF TOLEDO NA /OH/ 26,000$97,5000.02%
Bedel Financial Consulting, Inc. 15,000$56,2500.01%
Legato Capital Management LLC 16,456$61,7100.01%
OCCUDO QUANTITATIVE STRATEGIES LP 19,623$73,5860.01%
Cornerstone Capital, Inc. 16,357$61,3390.01%
View complete list of OCUPHIRE PHARMA INC shareholders